Average Co-Inventor Count = 5.38
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. The Salk Institute for Biological Studies (7 from 576 patents)
2. Cytovia, Inc. (7 from 47 patents)
3. Euro-Celtique S.a. (5 from 270 patents)
4. Other (4 from 832,880 patents)
5. The University of Sydney (4 from 267 patents)
6. Mitobridge, Inc. (3 from 20 patents)
7. Cascade Prodrug Inc. (2 from 2 patents)
8. University of Michigan (1 from 3,384 patents)
9. Oregon Health & Science University (1 from 509 patents)
10. University of Oregon (1 from 139 patents)
11. Eckard Weber (0 patent)
12. Peter Barmettler (0 patent)
13. John F. W. Keana (0 patent)
28 patents:
1. 11440889 - Analogs of fexaramine and methods of making and using
2. 11420934 - PPAR agonists
3. 10815203 - Analogs of fexaramine and methods of making and using
4. 10550071 - PPAR agonists
5. 10450277 - Analogs of fexaramine and methods of making and using
6. 10301268 - Analogs of fexaramine and methods of making and using
7. 9938234 - PPAR agonists
8. 8883775 - Treatment of hyperproliferative diseases with vinca alkaloid N-oxide analogs
9. 8410075 - Mannich base N-oxide drugs
10. 8048872 - Treatment of hyperproliferative diseases with vinca alkaloid N-oxide and analogs
11. 7557251 - Production of gossypol co-crystals
12. 7270801 - Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof
13. 6949516 - Dipeptide apoptosis inhibitors and the use thereof
14. 6800657 - Substituted 5-oxo-5, 6, 7, 8-tetrahydro-4H-1-benzopyrans
15. 6759207 - Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof